ADAM17 and COVID-19: Given the diverse roles of ADAM17 in the development of COVID-19, this strategy highlights the potential of ADAM17 inhibitors as a promising option for treating COVID-19, emphasizing the need for additional research to assess their effectiveness and safety in clinical settings.